The continuing operations EBITDA for the 2020 quarter was CHF157 million, down 14% in Swiss francs from CHF183 million a year earlier due to the decline in sales. However, the company emphasizes the resilience of the EBITDA margin at 15.4% compared to 15.7% in 1Q 2019, underpinned by 'rapid and efficient implementation' of cost control measures, it reports.

By region, Latin America and the Middle East and Africa were the only areas to achieve sales increases in local currency terms. Despite the impact of COVID-19 in China during 1Q 2020, sales development in Asia was 'robust' overall, according to the company, with a contraction in the low single-digit range. Sales in North America decreased slightly but weakened significantly in Europe. By business area (BA), the Natural Resources BA, which now includes the Additives business, posted a 2% increase in local currency sales in 1Q 2020. Sales in the Care Chemicals and Catalysis BAs declined. For the discontinued Masterbatches and Pigments operations, 1Q 2020 reported sales declined by 6% year on year in local currency and by 12% in Swiss francs.

Due to the COVID-19 pandemic, the entire chemicals industry was confronted by an 'unprecedented economic environment' in 1Q 2020, which, in the case of Clariant, was exacerbated by a mild winter season, the company says. Efforts to minimize the impact of the pandemic are 'fully in place' based on a strong balance sheet and liquidity position, Clariant reports.

**More information:** [www.clariant.com](http://www.clariant.com){#interrefs10}
